Pagliano, Pasquale Scarpati, Giuliana Sellitto, Carmine Conti, Valeria Spera, Anna Maria Ascione, Tiziana Piazza, Ornella Filippelli, Amelia
Published in
Journal of Experimental Pharmacology
The coronavirus infectious disease-2019 (COVID-19) has overwhelmed like a shock wave in a completely unprepared world. Despite coronavirus infections were involved in previous epidemic outbreaks, no antiviral agent was developed for specific treatment. As a consequence, since the beginning of this pandemic, both repositioned and experimental drugs ...
Rai, Gaurav S. Maru, Jayesh J.
Published in
Chemistry of Heterocyclic Compounds
This review summarizes diverse synthetic protocols for the preparation of pyrrolo[2,1- f ][1,2,4]triazine derivatives, covering literature sources from the past two decades. For effective representation, the synthetic methods toward the title compound are classified into six distinct categories: 1) synthesis from pyrrole derivatives, 2) synthesis v...
Abubakar, Abdullahi Rabiu Sani, Ibrahim Haruna Godman, Brian Kumar, Santosh Islam, Salequl Jahan, Iffat Haque, Mainul
Published in
Infection and Drug Resistance
A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and quickly spread globally. Several treatments have been proposed, many of which have proven ineffective. Consequently, there is a need to review the published evidence of drug clinical trials to guide future prescribing. A systematic review of published clinical trials and r...
Carrasco-Reinado, Rafael Escobar-Niño, Almudena Fajardo, Carlos Morano, Ines M Amil-Ruiz, Francisco Martinez-Rodríguez, Gonzalo Fuentes-Almagro, Carlos Capilla, Victoria Tomás-Cobos, Lidia Soriano-Romaní, Laura
...
Published in
International journal of molecular sciences
Proteomics is a crucial tool for unravelling the molecular dynamics of essential biological processes, becoming a pivotal technique for basic and applied research. Diverse bioinformatic tools are required to manage and explore the huge amount of information obtained from a single proteomics experiment. Thus, functional annotation and protein-protei...
Kalil, Andre C. Finberg, Robert W.
BACKGROUND: Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus remdesivir are not known. METHODS: We conducted a double-blind, randomized, placebo-controlled trial evaluating baricitinib plus remdesivir in hospitalized adults ...
Mun, Frederick Hale, Cory M Hennrikus, Eileen F
Published in
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
To determine how hospitals across the United States determined allocation criteria for remdesivir, approved in May 2020 for treatment of coronavirus disease 2019 (COVID-19) through an emergency use authorization, while maintaining fair and ethical distribution when patient needs exceeded supply. A electronic survey inquiring as to how institutions ...
Ashraf, Obaid Virani, Ahmed Cheema, Tariq
Published in
Critical Care Nursing Quarterly
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) remains a serious issue for global health, given widespread infectivity and a high contagion rate. A tremendous amount of data has been generated since it was first identified in December 2019. It is vital to keep up with these data from across the world at a...
Delorme-Axford, Elizabeth Klionsky, Daniel J
Published in
Autophagy
In the preceding months, the novel SARS-CoV-2 pandemic has devastated global communities. The need for safe and effective prophylactic and therapeutic treatments to combat COVID-19 - the human disease resulting from SARS-CoV-2 infection - is clear. Here, we present recent developments in the effort to combat COVID-19 and consider whether SARS-CoV-2...
Yatam Ganesh, Santosh Nachimuthu, Nagakrishnal
Published in
Cureus
Background Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause severe inflammation of the lungs resulting in acute respiratory distress syndrome (ARDS). Current treatment guidelines support use of remdesivir as well as dexamethasone in hypoxic patients. There is very little information known about use of inhal...
Pimentel, Juan Laurie, Cassandra Cockcroft, Anne Andersson, Neil
Published in
British journal of clinical pharmacology
Remdesivir is 1 of the repurposed drugs under investigation to treat patients with COVID-19. Clinicians and decision-makers need a summary of the most recent evidence. This scoping review maps the evidence on the efficacy, effectiveness and safety of remdesivir for patients with COVID-19, up to 14 September 2020. Our scoping review searched Pubmed,...